Moderna wins EU approval for combined flu, COVID shot for older adults

April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention of influenza and COVID-19 in adults 50 years of age and older. Here are the details: • The approval follows a positive recommendation from the European Medicines Agency,
Fierce Pharma

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines. In the phase 4 double-blind,

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s first authorized combination shot for the two respiratory viruses. The decision follows a positive review in February from a key European Medicines Agency’s committee, which paved the way for the approval.

Europe clears first flu/COVID combo shot from Moderna

Moderna Inc. MRNA shares are up on Tuesday as the company received marketing authorization for its mCOMBRIAX vaccine, the world’s first flu plus COVID-19 combination vaccine. Moderna Gains EU Nod For Combination Flu-COVID Vaccine The European Commission approved mCOMBRIAX,
Yahoo

EU regulator backs approval for Moderna's combined COVID and flu vaccine

Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the ‌first single shot to protect people aged 50 and older against both illnesses. Currently ...
KTVU

Moderna developing combo COVID-19 booster, flu shot

LOS ANGELES - Moderna announced on Thursday that it is currently developing a vaccine that combines a COVID-19 booster as well as a seasonal flu shot. "Today we are announcing the first step in our novel respiratory vaccine program with the development ...
Gizmodo

Moderna Has a Promising New Flu mRNA Vaccine. Trump’s FDA Wants Nothing to Do With It

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot. Reading time 3 minutes The federal government’s crusade against vaccines seems to have been taken up a notch.

Coronavirus: What's happening in Canada and around the world on Oct. 20

Many countries including Canada and the U.K. have backed mix-and-match strategies for the widely-used AstraZeneca-Oxford vaccine, which is not authorized in the United States but is based on similar viral vector technology as J&J's vaccine.